Logo

    beyond skin deep: impacts of psoriatic arthritis

    Explore " beyond skin deep: impacts of psoriatic arthritis" with insightful episodes like "Stories of Psoriatic Arthritis: A Mother's Journey to Recovery", "Stories of Psoriatic Arthritis: One Patient's Lifelong Affliction", "How PASI Scores Redefine Psoriatic Arthritis Patient Care", "The Emotional Toll of Psoriatic Skin Lesions" and "Stories of Psoriatic Arthritis: A Mother's Journey to Recovery" from podcasts like ""Beyond Skin Deep: Impacts of Psoriatic Arthritis", "Beyond Skin Deep: Impacts of Psoriatic Arthritis", "Beyond Skin Deep: Impacts of Psoriatic Arthritis", "Dermatology" and "Dermatology"" and more!

    Episodes (73)

    Stories of Psoriatic Arthritis: A Mother's Journey to Recovery

    Stories of Psoriatic Arthritis: A Mother's Journey to Recovery
    Host: Matt Birnholz, MD
    Guest: Robin K. Dore, MD

    As a physician, perhaps the only thing more satisfying than successfully treating a patient’s psoriatic arthritis is hearing their sincere gratitude for the positive impact the prescribed therapy has had on their life, as Dr. Robin Dore experienced in this patient case featuring a young mother who was apprehensive to begin treatment.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Stories of Psoriatic Arthritis: One Patient's Lifelong Affliction

    Stories of Psoriatic Arthritis: One Patient's Lifelong Affliction
    Host: Matt Birnholz, MD
    Guest: Robin Dore, MD

    Like any other condition, early detection is critical in psoriatic arthritis, but as Dr. Robin Dore proved in this unique patient case of a woman who dealt with PsA for 40 years, it’s never too late to start therapy and improve a patient’s quality of life.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    How PASI Scores Redefine Psoriatic Arthritis Patient Care

    How PASI Scores Redefine Psoriatic Arthritis Patient Care
    Guest: Robin K. Dore, MD

    Dr. Robin Dore joins us to answer some of the most frequently asked questions about PASI, like what these scores are, how they’re used, and how they affect the outcomes of your psoriatic arthritis patients.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    The Emotional Toll of Psoriatic Skin Lesions

    The Emotional Toll of Psoriatic Skin Lesions
    Guest: Robin K. Dore, MD

    The emotional burden of psoriatic arthritis stems from the development of skin lesions, which can be extremely damaging to a patient’s personal and professional relationships as Dr. Robin Dore explains.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Stories of Psoriatic Arthritis: A Mother's Journey to Recovery

    Stories of Psoriatic Arthritis: A Mother's Journey to Recovery
    Host: Matt Birnholz, MD
    Guest: Robin K. Dore, MD

    As a physician, perhaps the only thing more satisfying than successfully treating a patient’s psoriatic arthritis is hearing their sincere gratitude for the positive impact the prescribed therapy has had on their life, as Dr. Robin Dore experienced in this patient case featuring a young mother who was apprehensive to begin treatment.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Stories of Psoriatic Arthritis: One Patient's Lifelong Affliction

    Stories of Psoriatic Arthritis: One Patient's Lifelong Affliction
    Host: Matt Birnholz, MD
    Guest: Robin Dore, MD

    Like any other condition, early detection is critical in psoriatic arthritis, but as Dr. Robin Dore proved in this unique patient case of a woman who dealt with PsA for 40 years, it’s never too late to start therapy and improve a patient’s quality of life.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    How PASI Scores Redefine Psoriatic Arthritis Patient Care

    How PASI Scores Redefine Psoriatic Arthritis Patient Care
    Guest: Robin K. Dore, MD

    Dr. Robin Dore joins us to answer some of the most frequently asked questions about PASI, like what these scores are, how they’re used, and how they affect the outcomes of your psoriatic arthritis patients.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Understanding Treat-to-Target Strategy in the Management of PsA

    Understanding Treat-to-Target Strategy in the Management of PsA
    Guest: Elizabeth Volkmann, MD, MS

    What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Minimal Disease Activity as Alternate Target in PsA

    Minimal Disease Activity as Alternate Target in PsA
    Guest: Elizabeth Volkmann, MD, MS

    When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Minimal Disease Activity as Alternate Target in PsA

    Minimal Disease Activity as Alternate Target in PsA
    Guest: Elizabeth Volkmann, MD, MS

    When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Understanding Treat-to-Target Strategy in the Management of PsA

    Understanding Treat-to-Target Strategy in the Management of PsA
    Guest: Elizabeth Volkmann, MD, MS

    What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Understanding Treat-to-Target Strategy in the Management of PsA

    Understanding Treat-to-Target Strategy in the Management of PsA
    Guest: Elizabeth Volkmann, MD, MS

    What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Minimal Disease Activity as Alternate Target in PsA

    Minimal Disease Activity as Alternate Target in PsA
    Guest: Elizabeth Volkmann, MD, MS

    When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Minimal Disease Activity as Alternate Target in PsA

    Minimal Disease Activity as Alternate Target in PsA
    Guest: Elizabeth Volkmann, MD, MS

    When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Understanding Treat-to-Target Strategy in the Management of PsA

    Understanding Treat-to-Target Strategy in the Management of PsA
    Guest: Elizabeth Volkmann, MD, MS

    What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Minimal Disease Activity as Alternate Target in PsA

    Minimal Disease Activity as Alternate Target in PsA
    Guest: Elizabeth Volkmann, MD, MS

    When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Understanding Treat-to-Target Strategy in the Management of PsA

    Understanding Treat-to-Target Strategy in the Management of PsA
    Guest: Elizabeth Volkmann, MD, MS

    What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Why Clinical Skills are Crucial to Early Psoriatic Arthritis Diagnosis

    Why Clinical Skills are Crucial to Early Psoriatic Arthritis Diagnosis
    Guest: J. Eugene Huffstutter, MD

    Diagnosing psoriatic arthritis (PsA) requires a thorough and thoughtful exam, but how can you be sure you’re not missing any symptoms? Join Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, as he dives into the best ways to screen your PsA patients.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    The Impact of Positive Communication with PsA Patients

    The Impact of Positive Communication with PsA Patients
    Guest: J. Eugene Huffstutter, MD

    When you understand things from your patient’s perspective, you can have more powerful conversations about psoriatic arthritis (PsA) control. And to help you get inside a patient’s head, Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, describes the techniques he uses to understand a patient’s needs in order to find the best treatment option for their lifestyle.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    How You Can Overcome the Biggest Challenge in PsA Care Coordination

    How You Can Overcome the Biggest Challenge in PsA Care Coordination
    Guest: J. Eugene Huffstutter, MD

    Care coordination is key in ensuring that your psoriatic arthritis (PsA) patients maintain control of their disease, but it’s not always easy. To help you overcome this common challenge, Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, shares his perspective on how you can coordinate your PsA patients’ care with not only their healthcare team but also their family members.

    Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io